Clinical Trial Update: Comparison of Treximet & Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache

View source ↗

Summary

This completed trial compares Treximet (sumatriptan/naproxen) vs Imitrex (sumatriptan) in their effect on inflammatory markers during an active migraine attack.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Imitrex (Sumatriptan)
• TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: Gary E. Ruoff, M.D. | Conditions: Migraine | Status: COMPLETED